The global market for Targeted RNA Sequencing was estimated to be worth US$ 1800.6 million in 2023 and is forecast to a readjusted size of US$ 7570 million by 2030 with a CAGR of 22.5% during the forecast period 2024-2030

Targeted RNA Sequencing - Market

Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.

In the report, we only collect information about the companies who can provide targeted RNA sequencing service.

Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.

North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Targeted RNA Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Targeted RNA Sequencing by region & country, by Type, and by Application.

The Targeted RNA Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted RNA Sequencing.

Market Segmentation

Scope of Targeted RNA Sequencing - Market Report

Report Metric	Details
Report Name	Targeted RNA Sequencing - Market
Forecasted market size in 2030	US$ 7570 million
CAGR	22.5%
Forecasted years	2024 - 2030
Segment by Type:	Exome Sequencing Enrichment Sequencing Amplicon Sequencing
Segment by Application	Research Institutes Hospitals & Clinics Biotechnology Company Diagnostic Lab
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Targeted RNA Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Targeted RNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Targeted RNA Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Targeted RNA Sequencing - Market size in 2030?

Ans: The Targeted RNA Sequencing - Market size in 2030 will be US$ 7570 million.

What is the Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins share in Targeted RNA Sequencing - Market?

Ans: Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.

What is the Targeted RNA Sequencing - Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 32%.

Who are the main players in the Targeted RNA Sequencing - Market report?

Ans: The main players in the Targeted RNA Sequencing - Market are Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, GENEWIZ

What are the Application segmentation covered in the Targeted RNA Sequencing - Market report?

Ans: The Applications covered in the Targeted RNA Sequencing - Market report are Research Institutes, Hospitals & Clinics, Biotechnology Company, Diagnostic Lab

What are the Type segmentation covered in the Targeted RNA Sequencing - Market report?

Ans: The Types covered in the Targeted RNA Sequencing - Market report are Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing

1 Market Overview

1.1 Targeted RNA Sequencing Product Introduction

1.2 Global Targeted RNA Sequencing Market Size Forecast

1.3 Targeted RNA Sequencing Market Trends & Drivers

1.3.1 Targeted RNA Sequencing Industry Trends

1.3.2 Targeted RNA Sequencing Market Drivers & Opportunity

1.3.3 Targeted RNA Sequencing Market Challenges

1.3.4 Targeted RNA Sequencing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Targeted RNA Sequencing Players Revenue Ranking (2023)

2.2 Global Targeted RNA Sequencing Revenue by Company (2019-2024)

2.3 Key Companies Targeted RNA Sequencing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Targeted RNA Sequencing Product Offered

2.5 Key Companies Time to Begin Mass Production of Targeted RNA Sequencing

2.6 Targeted RNA Sequencing Market Competitive Analysis

2.6.1 Targeted RNA Sequencing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Targeted RNA Sequencing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted RNA Sequencing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Exome Sequencing

3.1.2 Enrichment Sequencing

3.1.3 Amplicon Sequencing

3.2 Global Targeted RNA Sequencing Sales Value by Type

3.2.1 Global Targeted RNA Sequencing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Targeted RNA Sequencing Sales Value, by Type (2019-2030)

3.2.3 Global Targeted RNA Sequencing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Research Institutes

4.1.2 Hospitals & Clinics

4.1.3 Biotechnology Company

4.1.4 Diagnostic Lab

4.2 Global Targeted RNA Sequencing Sales Value by Application

4.2.1 Global Targeted RNA Sequencing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Targeted RNA Sequencing Sales Value, by Application (2019-2030)

4.2.3 Global Targeted RNA Sequencing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Targeted RNA Sequencing Sales Value by Region

5.1.1 Global Targeted RNA Sequencing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Targeted RNA Sequencing Sales Value by Region (2019-2024)

5.1.3 Global Targeted RNA Sequencing Sales Value by Region (2025-2030)

5.1.4 Global Targeted RNA Sequencing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Targeted RNA Sequencing Sales Value, 2019-2030

5.2.2 North America Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Targeted RNA Sequencing Sales Value, 2019-2030

5.3.2 Europe Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Targeted RNA Sequencing Sales Value, 2019-2030

5.4.2 Asia Pacific Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Targeted RNA Sequencing Sales Value, 2019-2030

5.5.2 South America Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Targeted RNA Sequencing Sales Value, 2019-2030

5.6.2 Middle East & Africa Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Targeted RNA Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Targeted RNA Sequencing Sales Value

6.3 United States

6.3.1 United States Targeted RNA Sequencing Sales Value, 2019-2030

6.3.2 United States Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Targeted RNA Sequencing Sales Value, 2019-2030

6.4.2 Europe Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Targeted RNA Sequencing Sales Value, 2019-2030

6.5.2 China Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Targeted RNA Sequencing Sales Value, 2019-2030

6.6.2 Japan Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Targeted RNA Sequencing Sales Value, 2019-2030

6.7.2 South Korea Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Targeted RNA Sequencing Sales Value, 2019-2030

6.8.2 Southeast Asia Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Targeted RNA Sequencing Sales Value, 2019-2030

6.9.2 India Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Targeted RNA Sequencing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Thermo Fisher

7.1.1 Thermo Fisher Profile

7.1.2 Thermo Fisher Main Business

7.1.3 Thermo Fisher Targeted RNA Sequencing Products, Services and Solutions

7.1.4 Thermo Fisher Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.1.5 Thermo Fisher Recent Developments

7.2 Illumina

7.2.1 Illumina Profile

7.2.2 Illumina Main Business

7.2.3 Illumina Targeted RNA Sequencing Products, Services and Solutions

7.2.4 Illumina Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.2.5 Illumina Recent Developments

7.3 Roche Holdings

7.3.1 Roche Holdings Profile

7.3.2 Roche Holdings Main Business

7.3.3 Roche Holdings Targeted RNA Sequencing Products, Services and Solutions

7.3.4 Roche Holdings Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.3.5 BGI Recent Developments

7.4 BGI

7.4.1 BGI Profile

7.4.2 BGI Main Business

7.4.3 BGI Targeted RNA Sequencing Products, Services and Solutions

7.4.4 BGI Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.4.5 BGI Recent Developments

7.5 Eurofins

7.5.1 Eurofins Profile

7.5.2 Eurofins Main Business

7.5.3 Eurofins Targeted RNA Sequencing Products, Services and Solutions

7.5.4 Eurofins Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.5.5 Eurofins Recent Developments

7.6 LabCorp

7.6.1 LabCorp Profile

7.6.2 LabCorp Main Business

7.6.3 LabCorp Targeted RNA Sequencing Products, Services and Solutions

7.6.4 LabCorp Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.6.5 LabCorp Recent Developments

7.7 Berry Genomics

7.7.1 Berry Genomics Profile

7.7.2 Berry Genomics Main Business

7.7.3 Berry Genomics Targeted RNA Sequencing Products, Services and Solutions

7.7.4 Berry Genomics Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.7.5 Berry Genomics Recent Developments

7.8 Macrogen

7.8.1 Macrogen Profile

7.8.2 Macrogen Main Business

7.8.3 Macrogen Targeted RNA Sequencing Products, Services and Solutions

7.8.4 Macrogen Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.8.5 Macrogen Recent Developments

7.9 GENEWIZ

7.9.1 GENEWIZ Profile

7.9.2 GENEWIZ Main Business

7.9.3 GENEWIZ Targeted RNA Sequencing Products, Services and Solutions

7.9.4 GENEWIZ Targeted RNA Sequencing Revenue (US$ Million) & (2019-2024)

7.9.5 GENEWIZ Recent Developments

8 Industry Chain Analysis

8.1 Targeted RNA Sequencing Industrial Chain

8.2 Targeted RNA Sequencing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Targeted RNA Sequencing Sales Model

8.5.2 Sales Channel

8.5.3 Targeted RNA Sequencing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Targeted RNA Sequencing Market Trends

Table 2. Targeted RNA Sequencing Market Drivers & Opportunity

Table 3. Targeted RNA Sequencing Market Challenges

Table 4. Targeted RNA Sequencing Market Restraints

Table 5. Global Targeted RNA Sequencing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Targeted RNA Sequencing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Targeted RNA Sequencing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Targeted RNA Sequencing Product Type

Table 9. Key Companies Time to Begin Mass Production of Targeted RNA Sequencing

Table 10. Global Targeted RNA Sequencing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted RNA Sequencing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Targeted RNA Sequencing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Targeted RNA Sequencing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Targeted RNA Sequencing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Targeted RNA Sequencing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Targeted RNA Sequencing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Targeted RNA Sequencing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Targeted RNA Sequencing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Targeted RNA Sequencing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Targeted RNA Sequencing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Targeted RNA Sequencing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Targeted RNA Sequencing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Targeted RNA Sequencing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Targeted RNA Sequencing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Targeted RNA Sequencing Sales Value by Region (2019-2024) & (%)

Table 27. Global Targeted RNA Sequencing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Targeted RNA Sequencing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Targeted RNA Sequencing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Targeted RNA Sequencing Sales Value, (2025-2030) & (US$ Million)

Table 31. Thermo Fisher Basic Information List

Table 32. Thermo Fisher Description and Business Overview

Table 33. Thermo Fisher Targeted RNA Sequencing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Targeted RNA Sequencing Business of Thermo Fisher (2019-2024)

Table 35. Thermo Fisher Recent Developments

Table 36. Illumina Basic Information List

Table 37. Illumina Description and Business Overview

Table 38. Illumina Targeted RNA Sequencing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Targeted RNA Sequencing Business of Illumina (2019-2024)

Table 40. Illumina Recent Developments

Table 41. Roche Holdings Basic Information List

Table 42. Roche Holdings Description and Business Overview

Table 43. Roche Holdings Targeted RNA Sequencing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Targeted RNA Sequencing Business of Roche Holdings (2019-2024)

Table 45. Roche Holdings Recent Developments

Table 46. BGI Basic Information List

Table 47. BGI Description and Business Overview

Table 48. BGI Targeted RNA Sequencing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Targeted RNA Sequencing Business of BGI (2019-2024)

Table 50. BGI Recent Developments

Table 51. Eurofins Basic Information List

Table 52. Eurofins Description and Business Overview

Table 53. Eurofins Targeted RNA Sequencing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Targeted RNA Sequencing Business of Eurofins (2019-2024)

Table 55. Eurofins Recent Developments

Table 56. LabCorp Basic Information List

Table 57. LabCorp Description and Business Overview

Table 58. LabCorp Targeted RNA Sequencing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Targeted RNA Sequencing Business of LabCorp (2019-2024)

Table 60. LabCorp Recent Developments

Table 61. Berry Genomics Basic Information List

Table 62. Berry Genomics Description and Business Overview

Table 63. Berry Genomics Targeted RNA Sequencing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Targeted RNA Sequencing Business of Berry Genomics (2019-2024)

Table 65. Berry Genomics Recent Developments

Table 66. Macrogen Basic Information List

Table 67. Macrogen Description and Business Overview

Table 68. Macrogen Targeted RNA Sequencing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Targeted RNA Sequencing Business of Macrogen (2019-2024)

Table 70. Macrogen Recent Developments

Table 71. GENEWIZ Basic Information List

Table 72. GENEWIZ Description and Business Overview

Table 73. GENEWIZ Targeted RNA Sequencing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Targeted RNA Sequencing Business of GENEWIZ (2019-2024)

Table 75. GENEWIZ Recent Developments

Table 76. Key Raw Materials Lists

Table 77. Raw Materials Key Suppliers Lists

Table 78. Targeted RNA Sequencing Downstream Customers

Table 79. Targeted RNA Sequencing Distributors List

Table 80. Research Programs/Design for This Report

Table 81. Key Data Information from Secondary Sources

Table 82. Key Data Information from Primary Sources

Table 83. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Targeted RNA Sequencing Product Picture

Figure 2. Global Targeted RNA Sequencing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Targeted RNA Sequencing Sales Value (2019-2030) & (US$ Million)

Figure 4. Targeted RNA Sequencing Report Years Considered

Figure 5. Global Targeted RNA Sequencing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeted RNA Sequencing Revenue in 2023

Figure 7. Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Exome Sequencing Picture

Figure 9. Enrichment Sequencing Picture

Figure 10. Amplicon Sequencing Picture

Figure 11. Global Targeted RNA Sequencing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Targeted RNA Sequencing Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Research Institutes

Figure 14. Product Picture of Hospitals & Clinics

Figure 15. Product Picture of Biotechnology Company

Figure 16. Product Picture of Diagnostic Lab

Figure 17. Global Targeted RNA Sequencing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Targeted RNA Sequencing Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America Targeted RNA Sequencing Sales Value (2019-2030) & (US$ Million)

Figure 20. North America Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe Targeted RNA Sequencing Sales Value (2019-2030) & (US$ Million)

Figure 22. Europe Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific Targeted RNA Sequencing Sales Value (2019-2030) & (US$ Million)

Figure 24. Asia Pacific Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

Figure 25. South America Targeted RNA Sequencing Sales Value (2019-2030) & (US$ Million)

Figure 26. South America Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa Targeted RNA Sequencing Sales Value (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa Targeted RNA Sequencing Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions Targeted RNA Sequencing Sales Value (%), (2019-2030)

Figure 30. United States Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 32. United States Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 36. China Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 37. China Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 38. China Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 48. India Targeted RNA Sequencing Sales Value, (2019-2030) & (US$ Million)

Figure 49. India Targeted RNA Sequencing Sales Value by Type (%), 2023 VS 2030

Figure 50. India Targeted RNA Sequencing Sales Value by Application (%), 2023 VS 2030

Figure 51. Targeted RNA Sequencing Industrial Chain

Figure 52. Targeted RNA Sequencing Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions